☆ 4.8 Review

Severe and Difficult-to-Treat Asthma in Adults

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Get Full Text
Add to Collection

Journal

NEW ENGLAND JOURNAL OF MEDICINE
Volume 377, Issue 10, Pages 965-976

Publisher

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMra1608969

Keywords

-

Categories

Medicine, General & Internal

Funding

  1. AstraZeneca
  2. Cowen Co.
  3. Philips Respironics
  4. Regeneron
  5. Teva Specialty Pharmaceuticals
  6. Bird Rock Bio
  7. Nuvelution Pharmaceutical
  8. Vitaeris
  9. Entrinsic Health Solutions
  10. Merck
  11. Sanofi
  12. Novartis
  13. Genentech
  14. Boehringer Ingelheim
  15. GlaxoSmithKline
  16. Sunovion
  17. Mundipharma
  18. Teva

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.